Evidence map›Paper›PMID 32666453›Full record

ArticleEnvironmental science and pollution research international2020

Protective effects of Artemisia judaica extract compared to metformin against hepatorenal injury in high-fat diet/streptozotocine-induced diabetic rats.

Gadah Albasher, Mona Alwahaibi, Mohamed M Abdel-Daim, Saad Alkahtani, Rafa Almeer

Abstract read
PubMed Publisher
In one paragraph

Article in Environmental science and pollution research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. AqueousPharmaceutics · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Antioxidant Effect of the Ethyl Acetate Extract ofPlants (Basel, Switzerland) · 2023
    Article
  10. Journal of pharmacopuncture · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Role and mechanism(s) of incretin-dependent therapies for treating diabetes mellitus.Environmental science and pollution research international · 2022
    Review
  15. Article
  16. In Vitro and In Vivo Studies of Anti-Lung Cancer Activity ofAntioxidants (Basel, Switzerland) · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Aqueous and alcoholic extracts ofAvicenna journal of phytomedicine
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Gadah AlbasherDepartment of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia. galbeshr3@gmail.com.ORCID http://orcid.org/0000-0003-3755-7534
Mona AlwahaibiDepartment of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Mohamed M Abdel-DaimDepartment of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Saad AlkahtaniDepartment of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Rafa AlmeerDepartment of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.
King Saud University · SASuez Canal University · EG

Funding

King Saud University RSP-2020/95
6 · The paper itself

Abstract

Diabetes mellitus (DM) is one of the most dangerous incurable diseases that affects a large number of people worldwide. Artemisia species have various protective activities and are widely used for the control of diabetes in folkloric medicine. Therefore, the current study was designed to illustrate the protective effect of oral administration of Artemisia judaica extract (AjE) against hepatorenal damage in a high-fat diet/streptozotocin (HFD/STZ) rat model of hyperlipidemia and hyperglycemia. Animals were divided into five groups-control, AjE, HFD/STZ, HFD/STZ-AjE (300 mg/kg), and HFD/STZ-MET (100 mg/kg)-and treated daily for 28 days. The results revealed that STZ-injected rats showed marked hyperglycemia and hypoinsulinemia in addition to high levels of cholesterol, triglycerides, and low- and high-density lipoproteins compared to control rats. Significant elevations in hepatic (AST and ALT) and renal (urea, uric acid, and creatinine) function markers were observed in the serum of diabetic rats. Additionally, STZ injection caused remarkable elevations in lipid peroxidation and nitric oxide levels as well as suppression of antioxidant markers (superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, and glutathione). Marked elevations in TNF-α and Bax levels with a decline in Bcl-2 levels were detected after STZ injection. Furthermore, TGF-β1 expression levels were significantly upregulated in the liver and kidney tissues. Rats that received AjE or MET showed significant improvement in most of the aforementioned parameters, and the protective efficacy was higher for AjE than for MET. Histopathological screening confirmed the biochemical findings. Conclusively, our results illustrated the antihyperglycemic, antihyperlipidemic, antioxidant, anti-inflammatory, and antiapoptotic activities of AjE against hepatorenal injury in HFD/STZ-induced diabetes.

Indexed as

ArtemisiaDiabetes Mellitus, ExperimentalMetforminAnimalsAntioxidantsBlood GlucoseDiet, High-FatLiverOxidative StressPlant ExtractsRatsStreptozocinAntioxidantsBlood GlucoseMetforminPlant ExtractsStreptozocinArtemisia judaicaDiabetesGlycemiaHigh-fat dietLipid profileMetforminOxidative stressTGF-β1

Identifiers

PMID32666453
OpenAlexW3042519842

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.